Zobrazeno 241 - 250
of 3 816
pro vyhledávání: ''
Publikováno v:
Gastric Cancer. 23:550-560
Despite multiple clinical trials and practice guidelines for the treatment of gastric cancer, oncologic outcomes have not improved in the United States. One potential reason could be differences in the quality of surgery as performed in a controlled
Autor:
Y. lupiañez, R. Correa, J. A. Medina, I. Zapata, Ana Otero, J.M. Rico, M. Lobato, I. Navarro, J. Gomez-Millan, I. Jerez, David Olmos
Publikováno v:
Clinical and Translational Oncology. 22:311-318
To analyze the differences in toxicity and biochemical relapse-free survival with hypofractionated radiotherapy with three-dimensional radiotherapy (3D-CRT) or volumetric arc therapy (VMAT) for prostate cancer taking into account comorbidity measured
Autor:
Fangfang Wu, Zeyuan Liu, Hongjun Gao, Xiuhua Tang, Xiaoqing Liu, Shaoxing Yang, Haifeng Qin, Panpan Lv, Wenjing Liu
Publikováno v:
Thoracic Cancer, Vol 11, Iss 1, Pp 29-40 (2020)
Thoracic Cancer
Thoracic Cancer
Background Epidermal growth factor receptor (EGFR) gene mutations predict tumor response to EGFR tyrosine kinase inhibitors (EGFR‐TKIs) in non‐small cell lung cancer (NSCLC). However, even patients with EGFR‐sensitive mutations in NSCLC have li
Publikováno v:
Anticancer Research. 39:6291-6297
BACKGROUND/AIM Cyclins D1 and E play different roles in the cell cycle. Cyclin E promotes chromosome instability, whereas cyclin D1 regulates apoptosis of cells. This study evaluated the prognostic significance of G1 cyclins, p21 and pRb in tumor pro
Publikováno v:
Cancer Biomarkers. 26:361-366
Background Hepatocellular carcinoma (HCC) is the sixth most common malignant tumor and second most common cause of tumor-related deaths worldwide. Activated platelets play a prominent role in tumor. Platelet distribution width (PDW) indicates platele
Publikováno v:
Future Oncology. 15:3797-3807
Aim: To evaluate the role of preoperative platelet distribution width (PDW) as a potential biomarker for distinguishing malignancy and tumor advantage of bladder neoplasm. Methods: The study included 210 subjects with bladder cancer, 76 subjects with
Autor:
Xin Wang, Qi Wang, Liming Xu, Daquan Wang, Ping Wang, Zhenzhen Yin, Jinlin Zhao, Lujun Zhao, Jiaqi Zhang, Li Zhu, Shuai Wang
Publikováno v:
Future Oncology. 15:3701-3709
Aim: Adequate lymph node evaluation is recommended in patients with malignant tumors. However, the role of negative lymph nodes (NLNs) remains unclear in breast cancer (BC), especially in patients who have received neoadjuvant chemotherapy and mastec
Autor:
Terumasa Yamada, Shigeyuki Tamura, Jin Matsuyama, Kazuhiro Nishikawa, Kazumasa Fujitani, Masakazu Ikenaga, Yasutsuna Sasaki, Shunji Endo
Publikováno v:
Anticancer Research. 39:6209-6216
Background The appropriate extent of lymphadenectomy on gastric cancer patients with positive peritoneal cytology (CY1) is uncertain. This study retrospectively compared overall survival (OS) after standard and limited lymphadenectomy. Patients and m
Autor:
Wei Jiang, Jing-Lin Mi, Yuan Xie, Jin-Fang Fan, Yufei Pan, Da-Cheng Yao, Xiao-Li Qin, Yuan-Yuan Zhou, Yi Feng, Shu-Fang Liao
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 146:429-439
To compare the clinical results and functional outcomes between two-dimensional conventional radiation therapy (2DRT) and intensity-modulated radiation therapy (IMRT) in nasopharyngeal carcinoma (NPC) with skull-base invasion. A total of 1258 patient
Autor:
Shoko Yamashita, Yuji Morine, Yusuke Arakawa, Yuma Wada, Shogo Ohta, Satoru Imura, Yoshimi Bando, Tetsuya Ikemoto, Shinichiro Yamada, Yu Saito, Shuichi Iwahashi, Mitsuo Shimada
Publikováno v:
Anticancer Research. 39:6025-6033
Background/aim Carbohydrate antigen 19-9 (CA19-9) is a poor prognostic marker in intrahepatic cholangiocarcinoma (IHCC). Previous studies have shown a link between hypoxia and CA19-9 in cancer, and we have previously demonstrated a correlation betwee